E.S. Barr & Co’s Pfizer PFE Stock Holding History

E.S. Barr & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,524	Closed	-$586K	–	123
2025 Q4	$586K	Buy	+23,524	New	+$593K	0.03%	75
2024 Q4	–	Sell	-7,680	Closed	-$222K	–	110
2024 Q3	$222K	Sell	7,680 -1,088	-12%	-$31.7K	0.01%	98
2024 Q2	$245K	Sell	8,768 -140	-2%	-$3.85K	0.02%	86
2024 Q1	$247K	Sell	8,908 -945	-10%	-$26.2K	0.02%	84
2023 Q4	$284K	Buy	9,853 +945	+11%	+$28.6K	0.02%	80
2023 Q3	$295K	Sell	8,908 -100	-1%	-$3.54K	0.02%	78
2023 Q2	$330K	Hold	9,008	–	–	0.02%	77
2023 Q1	$368K	Sell	9,008 -1,500	-14%	-$64.8K	0.03%	69
2022 Q4	$538K	Hold	10,508	–	–	0.04%	63
2022 Q3	$460K	Sell	10,508 -506	-5%	-$24.6K	0.04%	65
2022 Q2	$577K	Sell	11,014 -3,342	-23%	-$170K	0.05%	63
2022 Q1	$743K	Sell	14,356 -1,000	-7%	-$51.9K	0.05%	61
2021 Q4	$907K	Sell	15,356 -57	-0.4%	-$2.82K	0.06%	60
2021 Q3	$663K	Buy	15,413 +57	+0.4%	+$2.52K	0.05%	62
2021 Q2	$601K	Buy	15,356 +3,038	+25%	+$118K	0.04%	65
2021 Q1	$446K	Sell	12,318 -75	-0.6%	-$2.66K	0.04%	64
2020 Q4	$456K	Buy	12,393 +2,282	+23%	+$83.7K	0.04%	60
2020 Q3	$352K	Sell	10,111 -328	-3%	-$11.5K	0.03%	63
2020 Q2	$324K	Sell	10,439 -1,265	-11%	-$43K	0.03%	68
2020 Q1	$362K	Sell	11,704 -2,243	-16%	-$76.4K	0.04%	60
2019 Q4	$518K	Hold	13,947	–	–	0.05%	60
2019 Q3	$475K	Hold	13,947	–	–	0.05%	60
2019 Q2	$573K	Sell	13,947 -377	-3%	-$15K	0.06%	57
2019 Q1	$577K	Sell	14,324 -1,446	-9%	-$57.9K	0.06%	58
2018 Q4	$653K	Hold	15,770	–	–	0.07%	56
2018 Q3	$659K	Buy	15,770 +34	+0.2%	+$1.31K	0.06%	61
2018 Q2	$542K	Hold	15,736	–	–	0.06%	67
2018 Q1	$530K	Buy	15,736 +328	+2%	+$11.3K	0.06%	65
2017 Q4	$530K	Buy	15,408 +73	+0.5%	+$2.49K	0.05%	65
2017 Q3	$519K	Buy	15,335 +349	+2%	+$11.2K	0.06%	62
2017 Q2	$478K	Hold	14,986	–	–	0.05%	63
2017 Q1	$486K	Sell	14,986 -1,828	-11%	-$57.6K	0.06%	60
2016 Q4	$518K	Buy	16,814 +377	+2%	+$11.5K	0.06%	61
2016 Q3	$528K	Sell	16,437 -3,231	-16%	-$108K	0.06%	59
2016 Q2	$657K	Hold	19,668	–	–	0.08%	56
2016 Q1	$553K	Sell	19,668 -718	-4%	-$20.5K	0.07%	59
2015 Q4	$624K	Hold	20,386	–	–	0.08%	59
2015 Q3	$608K	Buy	20,386 +713	+4%	+$22.9K	0.08%	57
2015 Q2	$626K	Hold	19,673	–	–	0.07%	56
2015 Q1	$649K	Sell	19,673 -237	-1%	-$7.54K	0.08%	55
2014 Q4	$588K	Sell	19,910 -3,872	-16%	-$111K	0.07%	58
2014 Q3	$667K	Sell	23,782 -257	-1%	-$7.21K	0.08%	59
2014 Q2	$677K	Buy	24,039 +2,401	+11%	+$68.4K	0.08%	57
2014 Q1	$659K	Buy	21,638 +32	+0.1%	+$954	0.08%	59
2013 Q4	$628K	Buy	21,606 +1,737	+9%	+$50.6K	0.08%	59
2013 Q3	$541K	Buy	19,869 +65	+0.3%	+$1.77K	0.07%	57
2013 Q2	$526K	Buy	+19,804	New	+$547K	0.07%	59

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

E.S. Barr & Co's PFE Position: Q1 2026 in Review

E.S. Barr & Co sold out of Pfizer (PFE) in Q1 2026, closing a stake of 23,524 shares — an estimated $586K sold.

E.S. Barr & Co first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $907K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

E.S. Barr & Co reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
E.S. Barr & Co sold 23,524 Pfizer shares in Q1 2026, an estimated $586K.
E.S. Barr & Co first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
E.S. Barr & Co's Pfizer position peaked at $907K in Q4 2021.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on E.S. Barr & Co's 13F filing for Q1 2026, filed 13 May 2026.